Stockscreener 앱 받기
58.90
1.04%
-0.62
시간 외 거래:
58.90
Haemonetics Corp 주식(HAE)의 최신 뉴스
London Co. of Virginia Decreases Stake in Haemonetics Corporation $HAE - MarketBeat
Haemonetics Corporation (HAE) Stock Price Prediction for 2026, 2030-2040 - Traders Union
Why Haemonetics (HAE) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Haemonetics Corporation $HAE Shares Purchased by Invenomic Capital Management LP - MarketBeat
Haemonetics Corporation (NYSE:HAE) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Haemonetics Corp Stock (ISIN: US4041191090) Faces Pressure Amid Hospital Recovery and Debt Concerns - AD HOC NEWS
Is Haemonetics (HAE) Quietly Rewiring Its Margin Profile Through NexSys PCS And Hospital Acquisitions? - simplywall.st
Does Haemonetics' (HAE) Hospital Rebound and NexSys Expansion Reframe Its Competitive Positioning? - Yahoo Finance
Aristotle Capital Boston LLC Increases Stock Position in Haemonetics Corporation $HAE - MarketBeat
Citi Maintains Haemonetics(HAE.US) With Hold Rating, Cuts Target Price to $70 - 富途牛牛
Haemonetics Corp Stock (ISIN: US4041191090) Expands Hospital Portfolio Amid Valuation Discount and A - AD HOC NEWS
Citi Maintains Haemonetics(HAE.US) With Hold Rating, Maintains Target Price $70 - 富途牛牛
Haemonetics Expands Hospital Portfolio As Investors Weigh Growth And Valuation - simplywall.st
Haemonetics Corp. Experiences Revision in Its Stock Evaluation Amid Market Dynamics - Markets Mojo
Haemonetics Corporation $HAE Shares Sold by Schroder Investment Management Group - MarketBeat
A Look At Haemonetics (HAE) Valuation After Recent Share Price Weakness - simplywall.st
Is it Apt to Retain Haemonetics Stock in Your Portfolio for Now? - Yahoo Finance
Haemonetics Corporation $HAE Shares Acquired by Barrow Hanley Mewhinney & Strauss LLC - MarketBeat
Haemonetics price target lowered to $70 from $75 at Citi - TipRanks
Citigroup Maintains Neutral Rating on Haemonetics (HAE), Lowers Price Target | HAE Stock News - GuruFocus
Citigroup Issues Pessimistic Forecast for Haemonetics (NYSE:HAE) Stock Price - MarketBeat
Haemonetics launches recruitment drive to expand clinical support roles - Traders Union
HAE SEC FilingsHaemonetics Corp Mass 10-K, 10-Q, 8-K Forms - Stock Titan
Assessing Haemonetics (HAE) Valuation After Recent Share Price Pullback - Yahoo Finance
A Look Back at Medical Devices & SuppliesSpecialty Stocks’ Q4 Earnings: Haemonetics (NYSE:HAE) Vs The Rest Of The Pack - Yahoo Finance
A Review of Q4 Earnings for Medical Devices & Supplies Specialty Stocks: Comparing Haemonetics (NYSE:HAE) to Its Competitors - Bitget
Haemonetics Wins FDA Nod For Persona PLUS Plasma Growth Opportunity - simplywall.st
Haemonetics Corporation $HAE Shares Sold by Fisher Asset Management LLC - MarketBeat
Haemonetics Repays $300 Million Convertible Senior Notes Due 2026 - marketscreener.com
William Blair Investment Management LLC Buys 57,332 Shares of Haemonetics Corporation $HAE - MarketBeat
Haemonetics Corp repays outstanding 0.00% convertible senior notesSEC filing - marketscreener.com
Haemonetics repays $300 million convertible notes at maturity By Investing.com - Investing.com Canada
Haemonetics repays $300 million convertible notes at maturity - Investing.com
Haemonetics Retires 2026 Convertible Notes, Simplifies Capital Structure - TipRanks
Haemonetics repays $300M 0.00% convertible notes due 2026 in cash - TradingView
Haemonetics (NYSE: HAE) retires $300M zero-coupon 2026 convertible notes in cash - Stock Titan
Assessing Haemonetics (HAE) Valuation After FDA Clearance Of NexSys PCS Persona PLUS System - simplywall.st
Haemonetics at Raymond James: Strategic Growth and Challenges - Investing.com Nigeria
Haemonetics at Raymond James: Strategic Growth and Challenges By Investing.com - Investing.com Australia
Here's Why Haemonetics (HAE) is a Strong Value Stock - Yahoo Finance
Royce & Associates LP Sells 569,815 Shares of Haemonetics Corporation $HAE - MarketBeat
Vanguard Group Inc. Reduces Stock Position in Haemonetics Corporation $HAE - MarketBeat
Kestrel Investment Management Corp Purchases New Shares in Haemonetics Corporation $HAE - MarketBeat
Ameritas Investment Partners Inc. Has $636,000 Holdings in Haemonetics Corporation $HAE - MarketBeat
Is Haemonetics (HAE) Offering A Compelling Entry Point After Prolonged Share Price Weakness - simplywall.st
Haemonetics Corporation $HAE Stake Lessened by Citigroup Inc. - MarketBeat
Q1 EPS Estimates for Haemonetics Decreased by Zacks Research - MarketBeat
Fox Run Management L.L.C. Takes $1.36 Million Position in Haemonetics Corporation $HAE - MarketBeat
Haemonetics Completes Hemerus Medical Acquisition - Yahoo
Zacks Research Forecasts Increased Earnings for Haemonetics - MarketBeat
Therapeutic Apheresis Market to Reach US$ 6,009.58 Million - openPR.com
Haemonetics (HAE) Is Up 5.3% After FDA Clears NexSys PCS With Persona PLUS Technology - simplywall.st
Haemonetics receives FDA clearance for plasma collection system - Investing.com
Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology - PR Newswire
Clark Estates Inc. NY Takes $2.24 Million Position in Haemonetics Corporation $HAE - MarketBeat
New Haemonetics tech helps plasma centers collect more per donor - Stock Titan
0.85%
1.86%
자본화:
|
볼륨(24시간):